217 related articles for article (PubMed ID: 15905596)
21. Review article: acid suppression in non-variceal acute upper gastrointestinal bleeding.
Barkun AN; Cockeram AW; Plourde V; Fedorak RN
Aliment Pharmacol Ther; 1999 Dec; 13(12):1565-84. PubMed ID: 10594391
[TBL] [Abstract][Full Text] [Related]
22. Treatment of nonvariceal upper gastrointestinal bleeding.
Rivkin K; Lyakhovetskiy A
Am J Health Syst Pharm; 2005 Jun; 62(11):1159-70. PubMed ID: 15914876
[TBL] [Abstract][Full Text] [Related]
23. Utility of proton pump inhibitors in the treatment of gastrointestinal hemorrhage.
Martin RA
Conn Med; 2004 Aug; 68(7):435-8. PubMed ID: 15384242
[TBL] [Abstract][Full Text] [Related]
24. Independent risk factors of 30-day outcomes in 1264 patients with peptic ulcer bleeding in the USA: large ulcers do worse.
Camus M; Jensen DM; Kovacs TO; Jensen ME; Markovic D; Gornbein J
Aliment Pharmacol Ther; 2016 May; 43(10):1080-9. PubMed ID: 27000531
[TBL] [Abstract][Full Text] [Related]
25. Overview of pharmacologic agents for acid suppression in critically ill patients.
Welage LS
Am J Health Syst Pharm; 2005 May; 62(10 Suppl 2):S4-S10. PubMed ID: 15905600
[TBL] [Abstract][Full Text] [Related]
26. Critical review of acid suppression in nonvariceal, acute, uppergastrointestinal bleeding.
Yacyshyn BR; Thomson AB
Dig Dis; 2000; 18(3):117-28. PubMed ID: 11279330
[TBL] [Abstract][Full Text] [Related]
27. Outcomes of peptic ulcer bleeding following treatment with proton pump inhibitors in routine clinical practice: 935 patients with high- or low-risk stigmata.
Lanas A; Carrera-Lasfuentes P; García-Rodríguez LA; García S; Arroyo-Villarino MT; Ponce J; Bujanda L; Calleja JL; Polo-Tomas M; Calvet X; Feu F; Perez-Aisa A
Scand J Gastroenterol; 2014 Oct; 49(10):1181-90. PubMed ID: 25144754
[TBL] [Abstract][Full Text] [Related]
28. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis.
Alhazzani W; Alenezi F; Jaeschke RZ; Moayyedi P; Cook DJ
Crit Care Med; 2013 Mar; 41(3):693-705. PubMed ID: 23318494
[TBL] [Abstract][Full Text] [Related]
29. Esomeprazole for the treatment of peptic ulcer bleeding.
den Hoed CM; Kuipers EJ
Expert Rev Gastroenterol Hepatol; 2010 Dec; 4(6):679-95. PubMed ID: 21108587
[TBL] [Abstract][Full Text] [Related]
30. Comparing intravenous and oral proton pump inhibitor therapy for bleeding peptic ulcers following endoscopic management: a systematic review and meta-analysis.
Tringali A; Manta R; Sica M; Bassotti G; Marmo R; Mutignani M
Br J Clin Pharmacol; 2017 Aug; 83(8):1619-1635. PubMed ID: 28181291
[TBL] [Abstract][Full Text] [Related]
31. Proton pump inhibitor therapy for peptic ulcer bleeding: Cochrane collaboration meta-analysis of randomized controlled trials.
Leontiadis GI; Sharma VK; Howden CW
Mayo Clin Proc; 2007 Mar; 82(3):286-96. PubMed ID: 17352364
[TBL] [Abstract][Full Text] [Related]
32. Meta-analysis: the efficacy of intravenous H2-receptor antagonists in bleeding peptic ulcer.
Levine JE; Leontiadis GI; Sharma VK; Howden CW
Aliment Pharmacol Ther; 2002 Jun; 16(6):1137-42. PubMed ID: 12030956
[TBL] [Abstract][Full Text] [Related]
33. Treating patients with acute gastrointestinal bleeding or rebleeding.
Pisegna JR
Pharmacotherapy; 2003 Oct; 23(10 Pt 2):81S-86S. PubMed ID: 14587962
[TBL] [Abstract][Full Text] [Related]
34. Proton pump inhibitors for acid suppression in the intensive care unit: formulary considerations.
Devlin JW
Am J Health Syst Pharm; 2005 May; 62(10 Suppl 2):S24-30. PubMed ID: 15905598
[TBL] [Abstract][Full Text] [Related]
35. Intragastric pH with oral vs intravenous bolus plus infusion proton-pump inhibitor therapy in patients with bleeding ulcers.
Laine L; Shah A; Bemanian S
Gastroenterology; 2008 Jun; 134(7):1836-41. PubMed ID: 18423628
[TBL] [Abstract][Full Text] [Related]
36. The Role of Adjuvant Acid Suppression on the Outcomes of Bleeding Esophageal Varices after Endoscopic Variceal Ligation.
Wu CK; Liang CM; Hsu CN; Hung TH; Yuan LT; Nguang SH; Wang JW; Tseng KL; Ku MK; Yang SC; Tai WC; Shih CW; Hsu PI; Wu DC; Chuah SK
PLoS One; 2017; 12(1):e0169884. PubMed ID: 28118373
[TBL] [Abstract][Full Text] [Related]
37. [Do proton pump inhibitors after endoscopic control of acute ulcer hemorrhage have an advantage over H2 receptor antagonists?].
Prassler R; Hendrich H; Barnert J; Richter G; Fleischmann R; Wienbeck M
Z Gastroenterol; 1995 Aug; 33(8):431-4. PubMed ID: 7483734
[TBL] [Abstract][Full Text] [Related]
38. Management of NSAID-associated peptic ulcer disease.
Melcarne L; García-Iglesias P; Calvet X
Expert Rev Gastroenterol Hepatol; 2016 Jun; 10(6):723-33. PubMed ID: 26775657
[TBL] [Abstract][Full Text] [Related]
39. Effects of different omeprazole dosing on gastric pH in non-variceal upper gastrointestinal bleeding: A randomized prospective study.
Chwiesko A; Charkiewicz R; Niklinski J; Luczaj W; Skrzydlewska E; Milewski R; Baniukiewicz A; Wroblewski E; Rosolowski M; Dabrowski A
J Dig Dis; 2016 Sep; 17(9):588-599. PubMed ID: 27518195
[TBL] [Abstract][Full Text] [Related]
40. Intragastric pH with oral versus intravenous bolus plus infusion proton pump inhibitor therapy in patients with bleeding ulcers.
Lin HJ; Tsai JJ
Gastroenterology; 2008 Nov; 135(5):1804-5. PubMed ID: 18840442
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
